key: cord-0854110-4zyn8hx6 authors: Ling, Chang-quan title: Complementary and alternative medicine during COVID-19 pandemic: What we have done date: 2021-11-27 journal: J Integr Med DOI: 10.1016/j.joim.2021.11.008 sha: 66f0af69c452882ee36890aa173f75deb650c06c doc_id: 854110 cord_uid: 4zyn8hx6 nan The Journal of Integrative Medicine, as one of the main journals that publishes CAM scholarship, has actively contributed to the worldwide management of COVID-19 epidemic. From 2020 to 2021, various communications about the use of CAM techniques to manage COVID-19 have been promptly reported. Several of these works and their important impacts are summarized below. At the beginning of the COVID-19 epidemic, the rapid identification of effective treatment options was one of the principal approaches to slow or stop the global spread of the virus. At that time, several studies focused on screening potential anti-COVID-19 substances via bioinformatics analysis. As early as February 14, 2020, the Journal of Integrative Medicine reported an innovative discovery made by Zhang et al. [10] , which pinpointed 26 Chinese herbs with potential inhibitory effects against SARS-CoV-2. Several of these herbs are contained in the Qingfei Paidu decoction, which is of the key formulas that has been both confirmed by The National Health Commission of the Peoples' Republic of China and verified to be effective against COVID-19 [11, 12] . Later, the Journal of Integrative Medicine published a study by Zhang et al. [13] that used network pharmacology to examine the mechanism of Lung-toxin Dispelling Formula No. 1, another formula used to treat COVID-19 effectively. Further, Fuzimoto [14] used a literature review to analyze the effectiveness of the Chinese herb Artemisia annua in the treatment of coronavirus infection noting that A. annua constituents can impede the SARS-CoV-2 attachment, membrane fusion, and internalization into the host cells, as well as hinder the viral replication and transcription process. Because of these activities, Fuzimoto proposed that A. annua was a potential source of medicine for treating COVID-19. Dang et al. [16] described the clinical characteristics of COVID-19 in patients over 80 years of age, including high mortality rate, severe and nontypical symptoms, and lymphopenia; based on these characteristics, the authors recommended that early diagnosis of elderly individuals with suspected COVID-19 was extremely important and should rely on prompt application of viral nucleic acid tests. As time went by, more and more COVID-19 patients successfully recovered from the disease. Simultaneously, the effectiveness of CAM in the treatment of COVID-19 was gradually verified. On May 15, 2020, the Lancet published an article titled Use of Herbal Drugs to Treat COVID-19 Should be with Caution [17] . Soon, Fields [18] commented on this Lancet article in the Journal of Integrative Medicine. He claimed "While this is true of all drugs, herbal and otherwise, the data may be biased and deserve a scientific response. We believe these types of reports will unfairly and negatively impact the field of integrative medicine as a whole and must be answered with facts and statistics that more accurately represent the current situation." Further, a meta-analysis conducted by Fan et al. [19] revealed that Chinese herbal medicine could improve the symptoms and signs of COVID-19 patients, reduce the level of inflammation marker CRP, and accelerate the absorption of lung infections, which proved that Chinese medicine was an effective CAM treatment for COVID-19. Besides, several studies published in the Journal of Integrative Medicine reported that traditional Chinese medicine was a good adjuvant treatment for COVID-19. For example, a retrospective study by Zhang et al. [20] verified that traditional Chinese medicine could help Western medicine treatments to reduce the negative conversion time of fecal nucleic acid and the duration of negative conversion of pharyngeal-fecal nucleic acid. Further, Shi et al. [21] reported similar results and clarified that the effects of traditional Chinese medicine may be related to its anti-inflammatory effects. A meta-analysis by Wang et al. [22] showed that the Lianhua Qingwen Capsule can significantly improve the effect of Western medicine in alleviating COVID-19 symptoms. Also, the consumption of Chinese herbal medicine as a co-therapy with acupuncture [23, 24] was shown to be beneficial to COVID-19 treatment. Notwithstanding, Zhao et al. [25] pointed out that the current data from randomized controlled studies of COVID-19 were imperfect, and higher-quality evidence-based studies were still needed. Iranian residents reported by Dehgha et al. [27] revealed that about 84% of Iranians used at least one type of CAM during the COVID-19 outbreak, 57.5% used CAMs to prevent the transmission of COVID-19, and people's intention to use CAMs was associated with gender, place of residence, COVID-19 status, and source of information about CAMs. Although CAM has proved to be a useful treatment for COVID-19 patients, it is believed that vaccination is still the only way to ultimately control the prevalence of the COVID-19 pandemic [28] . With the global promotion of COVID-19 vaccination programs, whether people who are at high risk of serious and lethal complications from COVID-19 [18, 19] , such as cancer patients, should be vaccinated has been widely discussed. Especially in the early days of vaccine availability, when vaccine safety and efficacy data were incomplete for at-risk populations, the intention to receive the COVID-19 vaccine among cancer patients became an important issue. In China, Hong et al. [29] surveyed 2158 cancer patients and found that 36% had received the COVID-19 vaccine, 40% were willing to get vaccinated, and 24% refused to be vaccinated. They further found that a cancer patient's intention to receive the COVID-19 vaccine was affected by factors such as occupation, and their knowledge about and attitude towards the COVID-19 vaccine. The authors recommended that, for cancer patients, individualized vaccination plans should be developed based on case-history and patient needs. At present, COVID-19 is still a serious international issue. During 2020-2021, medical journals have reported various achievements of CAM practitioners from all over the world. In general, the COVID-19 epidemic is gradually being brought under effective control, thanks to the joint efforts of medical faculty, traditional medicine practitioners and analysts of evidence-based medicine. Undoubtedly, CAM has made significant contributions. In China, traditional Chinese medicine integrated with conventional medicine has effectively suppressed the spread of the COVID-19 epidemic and protected the health of many people. In the world, the traditional medicine of various nations also played an indelible role. The battle against COVID-19 continues. According to all the above accomplishments and experience, we, the CAM and conventional medicine practitioners, the vaccine and treatment developers, the healthcare administrators, medical and scientific researchers, patients and the general public, should be united to make joint efforts to end the spread of COVID-19. With the continued effort of each of these groups involved in administering and supporting CAM, the COVID-19 pandemic will be overcome soon. Clinical characteristics of coronavirus disease 2019 in China Coronavirus disease 2019 (COVID-19): A perspective from China Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) The epidemiology and clinical information about COVID-19 What are complementary and integrative methods? Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective Combating COVID-19 with integrated traditional Chinese and Western medicine in China The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older Use of herbal drugs to treat COVID-19 should be with caution Dangers of scientific bias against herbal drugs for coronavirus disease 2019 Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: current evidence with systematic review and meta-analysis Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: A retrospective cohort study Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019 Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: a cross-sectional study based on the theory of planned behavior Use of complementary and alternative medicine in general population during COVID-19 outbreak: a survey in Iran Viral targets for vaccines against COVID-19 Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey